PRE

Hudson Leogrande is the Founder and CEO of Comfrt — a multi-billion-dollar DTC brand projected to exceed $1 billion in revenue in 2026 Comfrt is one of the largest advertisers on both TikTok and Meta; Comfrt's 600,000-strong TikTok affiliate community drives organic cultural reach that unlocks Meta paid acquisition Mr. Leogrande joins David Beckham (Co-Founder), Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty, and Inter Miami CF in supporting IM8 to redefine the global health and longevity category IM8 crossed $100 million ARR in just 11 months and is projected to reach $250 million to $300 million ARR by the end of 2026 With this appointment, three of Prenetics' four directors are independent, reinforcing the Company's commitment to strong corporate governance NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced the appointment of Hudson Leogrande, Founder and Chief Executive Officer of Comfrt, to its Board of Directors (the “Board”) as an independent director, effective immediately.

SpaceX Launchpad's total subscription allocation has expanded to 7 million USDT, equivalent to 53,800 SPACE(PRE). The subscription price is set at 130 USDT

MEXC SPACEX(PRE) Launchpad is with total subscriptions surpassing $56 million and the most competitive pool reaching an oversubscription rate of 15.5x.

Multi-year partnership lands as Prenetics' IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8's first global ambassador from outside the world of sport Joins an equity-aligned roster of David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, and Inter Miami CF (with Lionel Messi) NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced a multi-year global partnership with #1 New York Times bestselling author and award-winning podcast host of On Purpose, and purpose-driven entrepreneur, Jay Shetty. Shetty becomes Global Ambassador of IM8 and a shareholder in Prenetics, demonstrating his long-term conviction in the brand and the Company.

Prenetics Global NASDAQ: PRE said its first-quarter results reflected the company's shift away from diagnostics and genome testing toward a subscription-driven consumer health model anchored by its IM8 supplement brand.

~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion

Prenetics records Q1 2026 revenue of  $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million) Company projects Q2 2026 revenue of $46 million to $48 million, with IM8 contributing $44 million to $46 million, representing approximately 33% sequential quarterly growth for IM8 IM8 announces the launch of 3 new SKUs in Q4 with Hydration, Creatine and Kids' Gummies Prenetics divests full stake of digital assets for $41.3 million in proceeds, further boosting its cash balance Prenetics executed approximately $19 million of previously announced $40 million share buyback program Appointed consumer supplements finance veteran Brian J. Rosin as Chief Financial Officer of IM8 Company to host earnings call on May 14, 2026, at 8:30 a.m.

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced it will release financial results for the first quarter 2026 ended March 31, 2026 before market open on Thursday, May 14, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m.

I am strongly bullish on Prenetics Global Limited, driven by the IM8 product and a successful shift to quarterly subscriptions doubling customer value. PRE's revenue is projected to grow 105.7% YoY in FY2026, with management guiding $180–$200 million, underpinned by robust international market adoption. IM8's rapid adoption fueled an 80% new customer subscription rate and increased average order value to $233, supporting PRE's high-growth valuation premium.